PAT-SC1 in patients with gastric cancer
Phase of Trial: Phase II
Latest Information Update: 27 Sep 2011
At a glance
- Drugs PAT SC1 (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Sponsors Patrys
- 27 Sep 2011 Status changed from planning to discontinued (trial is no longer being planned by Patrys).
- 24 Dec 2010 USA FDA confirms orphan drug status and PAT-SC1 is now being converted to Patrys' recently developed large scale manufacturing technology in preparation for a second trial.
- 27 May 2010 New trial record